(1) Does anyone think we can crack $50m royalties in this coming quarterly? My thinking is that it should have been an excellent quarter as production pretty much reached their increased capacity targets around the time of the last quarterly.
(2) Does anyone think they will increase capacity even further, they have already mentioned that production at "end of next year" will be well over 200m p.a. (what ever that means!!)... my thinking is that the tamiflu resistance issue is just too much of a risk for governments to continue lowballing the Relenza stockpile.
BTA Price at posting:
$2.97 Sentiment: Buy Disclosure: Held
